HIGHLIGHTS
- What: The authors report the effectiveness of monthly rifampicin, ofloxacin and minocycline in 29 individuals which was not associated with severe adverse effects. The authors report good clinical outcome in a cohort of 29 individuals who received mROM for leprosy and were followed for a median period of 3.1 years.
- Who: Priyanka Sivakumaran and collaborators from the Tropical Diseases, London, United Kingdom , Royal London Hospital, London, United Kingdom, Hospital for Tropical Diseases, University College have published the research: A retrospective cohort study of monthly rifampicin, ofloxacin and minocycline in the management of leprosy at . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.